Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Ribociclib|DRUG: Fulvestrant|DRUG: Placebo
Sponsor: Novartis Pharmaceuticals